Evidence map›Paper›PMID 32332775›Full record

ArticleScientific reports2020

Interleukin-1α associates with the tumor suppressor p53 following DNA damage.

J Novak, B Zamostna, V Vopalensky, M Buryskova, L Burysek, D Doleckova, M Pospisek

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

J NovakDepartment of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czech Republic.
B ZamostnaDepartment of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czech Republic.
V VopalenskyDepartment of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czech Republic.
M BuryskovaProtean s.r.o., Dobra Voda u Ceskych Budejovic, Czech Republic.
L BurysekProtean s.r.o., Dobra Voda u Ceskych Budejovic, Czech Republic.
D DoleckovaDepartment of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czech Republic.
M PospisekDepartment of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czech Republic. martin.pospisek@natur.cuni.cz.
Charles University · CZProtean (Czechia) · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin-1α (IL-1α) is a dual-function proinflammatory mediator. In addition to its role in the canonical IL-1 signaling pathway, which employs membrane-bound receptors, a growing body of evidence shows that IL-1α has some additional intracellular functions. We identified the interaction of IL-1α with the tumor suppressor p53 in the nuclei and cytoplasm of both malignant and noncancerous mammalian cell lines using immunoprecipitation and the in situ proximity ligation assay (PLA). This interaction was enhanced by treatment with the antineoplastic drug etoposide, which suggests a role for the IL-1α•p53 interaction in genotoxic stress.

Indexed as

Blotting, WesternCytoplasmDNA Breaks, Double-StrandedDNA DamageHeLa CellsHumansImmunoprecipitationInterleukin-1alphaMicroscopy, FluorescenceTumor Suppressor Protein p53Interleukin-1alphaTumor Suppressor Protein p53

Identifiers

PMID32332775
PMCPMC7181607
OpenAlexW3020073795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.